| Dr Barbara Leugh Kersey, PHD | |
|
880 Kempsville Rd, #2200, Norfolk, VA 23502-3931 | |
| (757) 466-6350 | |
| (757) 466-9262 |
| Full Name | Dr Barbara Leugh Kersey |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 880 Kempsville Rd, Norfolk, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801002274 | NPI | - | NPPES |
| 0717000141 | Other | VA | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 0717000141 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Barbara Leugh Kersey, PHD 880 Kempsville Rd, #2200, Norfolk, VA 23502-3931 Ph: (757) 466-6350 | Dr Barbara Leugh Kersey, PHD 880 Kempsville Rd, #2200, Norfolk, VA 23502-3931 Ph: (757) 466-6350 |
News Archive
ViroStatics, srl, an Italian-US biopharmaceutical company today announced the formation of a strategic partnership with Vichem Chemie of Budapest, Hungary to identify, synthesize, screen, and develop the next generation of AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs) for the treatment of HIV/AIDS and other chronic diseases.
A new Oregon State University study of children with autism found that they are more sedentary than their typically-developing peers, averaging 50 minutes less a day of moderate physical activity and 70 minutes more each day sitting.
Vermillion, Inc., a leading molecular diagnostics company, today announced positive results from a new prospective, multi-center clinical study of its ovarian cancer diagnostic OVA1.
Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.
Zogenix, Inc. and Desitin Pharmaceuticals GmbH today announced that the Danish Medicines Agency of Denmark has approved the Marketing Authorization Application (MAA) for SUMAVEL® DosePro™ (sumatriptan injection) Needle-Free Delivery System. Denmark is the first country in Europe to grant marketing authorization for SUMAVEL DosePro for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache.
› Verified 3 days ago
Mrs. Kristen Joy Kelly, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 7460 Central Business Park Dr, Norfolk, VA 23513 Phone: 757-644-6391 | |
Sarah Kooiman, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 426 E Freemason St Ste 250, Norfolk, VA 23510 Phone: 757-524-1636 | |
Mrs. Danielle Leibovici, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 222 W 19th St, Norfolk, VA 23517 Phone: 757-622-7017 | |
Armirah Stephens, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 250 W Brambleton Ave Ste 101, Norfolk, VA 23510 Phone: 757-781-1488 | |
Katelyn Shelby Wagner, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 802 Graydon Ave Apt A2, Norfolk, VA 23507 Phone: 602-568-2038 | |
Sarah C Stovall, Couples Therapy Medicare: Medicare Enrolled Practice Location: 110 Kingsley Ln Ste 106, Norfolk, VA 23505 Phone: 805-415-8544 | |
Ms. Bonita Hale Erb, LPC/LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 6330 Newtown Rd, Suite 300, Norfolk, VA 23502 Phone: 757-466-3336 Fax: 757-455-5750 |